Abstract
This is the first report of the use of botulinum toxin injected into the hand to treat complex regional pain syndrome (CRPS). Botulinum toxin has been shown to improve pain in Raynaud's syndrome, carpal tunnel syndrome, and CRPS of the lower limb. Botulinum toxin has also been shown to act on pain neurotransmitters directly. A 40-year-old man was referred to us with bilateral CRPS after falling onto his hands. Fifty units of Botox® were injected into the carpal tunnel and 50 units around the digital neurovascular bundles of the left non-dominant hand. Hand assessments were performed before injection, and weekly for 6 weeks post-injection. The dominant hand acted as a control. A steady improvement of power grip strength in the left hand was shown. Power in his left hand was greater than the right, despite him being right handed. Total active movement did not change significantly. He felt the injection was beneficial. Botulinum toxin may have improved the signs and symptoms of CRPS in the hand due to its combined effect on the vascular and nervous systems. Botulinum toxin may block the self-perpetuation cycle of pain and sympathetic stimulation by blocking neurotransmitters and warrants further studies on CRPS.
Similar content being viewed by others
References
Setler P (2002) Therapeutic use of botulinum toxins: background and history. Clin J Pain 18:S119–S124
Münchau A, Bhatia KP (2000) Uses of botulinum toxin injection in medicine today. BMJ 320(7228):161–165
Neumeister MW et al (2009) Botox therapy for ischaemic digits. Plast Reconstr Surg 124:191–200
Fregene A et al (2009) Botulinum toxin type A: a treatment option for digital ischaemia in patients with Raynaud’s phenomenon. J Hand Surg 34A:446–452
Van Beek AL et al (2007) Management of vasospastic disorders with botulinum toxin A. Plast Reconstr Surg 119:217–226
Sycha T et al (2004) Botulinum toxin in the treatment of Raynaud’s phenomenon: a pilot study. Euro J Clin Invest 34:312–313
McMahon HT et al (1992) Tetanus toxin and botulinum toxins type A and B inhibit glutamate, gamma-aminobutyric acid, aspartate, and met-enkephalin release from synaptosomes: clues to the locus of action. J Biol Chem 267:21338–21343
Carroll I et al (2009) Sympathetic block with botulinum toxin to treat complex regional pain syndrome. Ann Neurol 65(3):348–351
Argoff CE (2002) A foculsed review on the use of botulinum toxins for neuropathic pain. Clin J Pain 18(6):S177–S181
Tsai CP et al (2006) Efficacy of botulinum toxin type a in the relief of Carpal tunnel syndrome: a preliminary experience. Clin Drug Invest 26(9):511–515
Merskey H, Bogduk N (1994) Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. IASP, Seattle
Conflict of interest
None.
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ovens, L., Dewar, D. Use of botulinum toxin in complex regional pain syndrome in the hand. Eur J Plast Surg 36, 37–39 (2013). https://doi.org/10.1007/s00238-012-0711-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00238-012-0711-5